Webinar Download


Originally Hosted:
Thursday, November 15, 2018
11:30am-12:30pm EST

An Advanced Patented Tool to Streamline Formulation Development 

  • Enhanced IVIVC
  • Evaluate Formulations: Bioequivalence, Post Approval Changes, 505(b)(2) Formulations
  • Maximize Therapeutic Outcomes
  • Only Device Using a Live Biological Barrier

Presenter: Ismael Hidalgo, PhD
Chief Scientific Officer, Absorption Systems

As Chief Scientific Officer, Dr. Hidalgo is responsible for the scientific vision of Absorption Systems, planning, executing, and managing the scientific and technical operations of the company. He co-founded Absorption Systems with his business partner Patrick Dentinger in 1996. His work in pharmaceutics and in vitro pharmacokinetic models formed the basis for the original premise of Absorption Systems, which was that validated, reliable preclinical test systems could identify drug candidates with appropriate drug-like properties and help predict success in the clinic. Dr. Hidalgo is famous among pharmaceutical scientists for pioneering the Caco-2 cell monolayer, an in vitro model that predicts human oral drug absorption.  Read More >>